Cargando…

Polyphenol-based targeted therapy for oral submucous fibrosis

Oral submucous fibrosis (OSF) is a chronic, progressive, and precancerous condition mainly caused by chewing areca nut. Currently, OSF therapy includes intralesional injection of corticosteroids with limited therapeutic success in disease management. Therefore, a combined approach of in silico, in v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehta, Chetan Hasmukh, Paliwal, Shivangi, Muttigi, Manjunatha S., Seetharam, Raviraja N., Prasad, Alevoor Srinivas Bharath, Nayak, Yogendra, Acharya, Shruthi, Nayak, Usha Yogendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518296/ https://www.ncbi.nlm.nih.gov/pubmed/37106237 http://dx.doi.org/10.1007/s10787-023-01212-1

Ejemplares similares

Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment
por: Velagacherla, Varalakshmi, et al.
Publicado: (2023)

Comparative Evaluation of the Effectiveness of a Combination of Absorbable Gelatin Sponge and Calendula officinalis with Absorbable Gelatin Sponge Used Alone as a Hemostatic Agent—An In-Vitro Study
por: Ayyanahalli Matta, Bharath Kumar, et al.
Publicado: (2022)

A nanocomposite hydrogel delivery system for mesenchymal stromal cell secretome
por: Shoma Suresh, K., et al.
Publicado: (2020)

Pseudomonas aeruginosa virulence proteins pseudolysin and protease IV impede cutaneous wound healing
por: Prasad, Alevoor Srinivas Bharath, et al.
Publicado: (2020)

Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer
por: Baby, Krishnaprasad, et al.
Publicado: (2023)

Immunohistochemical Analysis of Vimentin in Oral Submucous Fibrosis
por: Nayak, Meghanand T., et al.
Publicado: (2013)

Carcinoma Arising in the Background of Oral Submucous Fibrosis
por: Rangaswamy, Shruthi, et al.
Publicado: (2019)

Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19
por: Baby, Krishnaprasad, et al.
Publicado: (2020)

Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study
por: Baby, Krishnaprasad, et al.
Publicado: (2021)

SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
por: Baby, Krishnaprasad, et al.
Publicado: (2021)

Identification of phytochemical as a dual inhibitor of PI3K and mTOR: a structure-based computational approach
por: Kumar, B. Harish, et al.
Publicado: (2022)

Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation
por: Karnam, Shyamala, et al.
Publicado: (2022)

Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis
por: Dsouza, Nikitha Naomi, et al.
Publicado: (2023)

Habit-associated salivary pH changes in oral submucous fibrosis: A cross-sectional study
por: Sahu, Rohit Kumar, et al.
Publicado: (2021)

Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity
por: Hamdy, Rania, et al.
Publicado: (2021)

Expression of cyclooxygenase 2 in oral submucous fibrosis: An immunohistochemical pilot study
por: Rangaswamy, Shruthi, et al.
Publicado: (2019)

Antimicrobial peptide polymers: no escape to ESKAPE pathogens—a review
por: Mukhopadhyay, Songhita, et al.
Publicado: (2020)

Oral submucous fibrosis: an update
por: Wollina, Uwe, et al.
Publicado: (2015)

Oral submucous fibrosis: An update
por: Ray, Jay Gopal, et al.
Publicado: (2017)

Localized In Situ Nanoemulgel Drug Delivery System of Quercetin for Periodontitis: Development and Computational Simulations
por: Aithal, Gururaj C., et al.
Publicado: (2018)

Gastroretentive Pulsatile Release Tablets of Lercanidipine HCl: Development, Statistical Optimization, and In Vitro and In Vivo Evaluation
por: Reddy, Gagganapalli Santhoshi, et al.
Publicado: (2014)

Plasma fibrinogen degradation products in oral submucous fibrosis
por: Gupta, Sonia, et al.
Publicado: (2015)

Anti-aging and Sunscreens: Paradigm Shift in Cosmetics
por: Shanbhag, Shreya, et al.
Publicado: (2019)

Lipid profile in oral submucous fibrosis
por: Mehrotra, Ravi, et al.
Publicado: (2009)

Medical management of oral submucous fibrosis
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2015)

The Beginning of a New Era: Artificial Intelligence in Healthcare
por: Kumar, Akshara, et al.
Publicado: (2021)

Assessment of epithelial–mesenchymal transition signatures in oral submucous fibrosis
por: Prasad, R Shesha, et al.
Publicado: (2019)

Oral Submucous Fibrosis: Correlation of Clinical Grading to Various Habit Factors
por: Jha, Vikash K., et al.
Publicado: (2019)

Estimation of argyrophilic nucleolar organizer regions in different grades of oral submucous fibrosis
por: Girish, KL, et al.
Publicado: (2015)

Role of programmed cell death 4 in myofibroblast differentiation in oral submucous fibrosis
por: Desai, Karishma Madhusudan, et al.
Publicado: (2021)

Habit-associated salivary pH changes in oral submucous fibrosis–A controlled cross-sectional study
por: Donoghue, Mandana, et al.
Publicado: (2015)

Management of Oral Submucous Fibrosis with Injection of Hyaluronidase and Dexamethasone in Grade III Oral Submucous Fibrosis: A Retrospective Study
por: James, Leena, et al.
Publicado: (2015)

Combination Therapy and Nanoparticulate Systems: Smart Approaches for the Effective Treatment of Breast Cancer
por: Gadag, Shivaprasad, et al.
Publicado: (2020)

Occurrence of Epithelial Atypia in 51 Indian Villagers with Oral Submucous Fibrosis
por: Pindborg, J. J., et al.
Publicado: (1970)

A New Intraoral Appliance for Trismus in Oral Submucous Fibrosis
por: Chaitanya, Nallan C. S. K., et al.
Publicado: (2018)

Prevalence of oral submucous fibrosis among 50,915 Indian villagers.
por: Pindborg, J. J., et al.
Publicado: (1968)

Submucous fibrosis of the oral cavity. Histomorphological studies.
por: Wahi, P. N., et al.
Publicado: (1966)

Proliferation and apoptosis markers in oral submucous fibrosis
por: Ranganathan, K, et al.
Publicado: (2011)

Oral submucous fibrosis and its dermatological relation
por: Ali, Fareedi Mukram, et al.
Publicado: (2014)

Pathogenesis and therapeutic intervention of oral submucous fibrosis
por: Yoithapprabhunath, Thukanaykanpalayam Ragunathan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vatuc5i626396t3e8oi3n9ucmh